| Original language | English |
|---|---|
| Pages (from-to) | 1505-1509 |
| Number of pages | 5 |
| Journal | Gastroenterology |
| Volume | 163 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - Dec 2022 |
| Externally published | Yes |
Keywords
- Bowel damage
- Disease progression
- Ulcerative colitis
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Gastroenterology, Vol. 163, No. 6, 12.2022, p. 1505-1509.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - A summary of the BRIDGe Summit on damage-related progression of ulcerative colitis
T2 - establishing research priorities
AU - BRIDGe UC Progression Summit Collaborators
AU - Krugliak Cleveland, Noa
AU - Bressler, Brian
AU - Siegel, Corey A.
AU - Baidoo, Leonard
AU - Cheifetz, Adam S.
AU - Colombel, Jean Frederic
AU - Deepak, Parakkal
AU - Devlin, Shane
AU - Irving, Peter M.
AU - Cleveland, Noa Krugliak
AU - Melmed, Gil Y.
AU - Raffals, Laura E.
AU - Rieder, Florian
AU - Rubin, David T.
AU - Sparrow, Miles P.
AU - Torres, Joana
AU - Ullman, Thomas
AU - Velayos, Fernando
N1 - Funding Information: The BRIDGe UC Progression Summit Collaborators: Leonard Baidoo (Regional One Health, Memphis, Tennessee), Brian Bressler (University of British Columbia, Vancouver, British Columbia, Canada), Adam S. Cheifetz (Beth Israel Deaconess Medical Center, Boston, Massachusetts), Jean-Frederic Colombel (The Mount Sinai Hospital, New York, New York), Parakkal Deepak (Washington University School of Medicine, St Louis, Missouri), Shane Devlin (University of Calgary, Calgary, Alberta, Canada), Peter M. Irving (Guy's and St. Thomas’ Hospitals, London, United Kingdom), Noa Krugliak Cleveland (University of Chicago Medicine, Chicago, Illinois), Gil Y. Melmed (Cedars-Sinai Medical Center, Los Angeles, California), Laura E. Raffals (Mayo Clinic, Rochester, Minnesota), Florian Rieder (Cleveland Clinic Foundation, Cleveland), David T. Rubin (University of Chicago Medicine, Chicago, Illinois), Corey A. Siegel (Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire), Miles P. Sparrow (The Alfred Hospital, Melbourne, Victoria, Australia), Joana Torres (Hospital Beatriz Ângelo, Loures, Lisbon, Portugal, Hospital da Luz, Lisbon, Portugal), Thomas Ullman (Montefiore Medical Center, New York, New York), and Fernando Velayos (University of California San Francisco, San Francisco, California). The authors thank Jennifer Greene, BRIDGe Program Manager, and Sonja Hunter and Jennifer Coughlin of MeetingLogistix for their assistance in planning and executing the summit. Writing Assistance, Editorial support in the form of medical writing was provided by Shira Berman with funding from the BRIDGe Group. Author Contributions, N. Krugliak Cleveland, B. Bressler, and C. A. Siegel planned the Summit and drafted the initial meeting summary. All authors critically reviewed the draft manuscript and approved the final version before submission. Funding Information: Funding This project was supported by unrestricted educational grants from AbbVie Inc, Pfizer Inc, and Eli Lilly and Co. Supporters were invited to observe the meeting, but had no role in its development or execution and did not review the article before publication. Funding Information: Editorial support in the form of medical writing was provided by Shira Berman with funding from the BRIDGe Group.
PY - 2022/12
Y1 - 2022/12
KW - Bowel damage
KW - Disease progression
KW - Ulcerative colitis
UR - http://www.scopus.com/inward/record.url?scp=85139939408&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2022.08.013
DO - 10.1053/j.gastro.2022.08.013
M3 - Article
C2 - 35964690
AN - SCOPUS:85139939408
SN - 0016-5085
VL - 163
SP - 1505
EP - 1509
JO - Gastroenterology
JF - Gastroenterology
IS - 6
ER -